Dr. Nemoyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Pattersen St Suite 596
Meb Robert Wood Johnson University Hospital
New Brunswick, NJ 08901Phone+1 732-235-7674
Education & Training
- Cleveland Clinic FoundationFellowship, Thoracic Surgery, 2021 - 2023
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2014 - 2021
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2014
Certifications & Licensure
- NJ State Medical License 2018 - 2025
- OH State Medical License 2021 - 2025
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- AATS Robotic Fellowship AATS, 2022-2023
Publications & Presentations
PubMed
- 9 citationsBone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells.Arindam Mondal, Rachel NeMoyer, Mehul Vora, Logan Napoli, Zoya Syed
Cell Communication and Signaling. 2021-09-25 - 36 citationsUse of the six core surgical indicators from the Lancet commission on global surgery in Colombia: a situational analysisJoseph S. Hanna, Gabriel Herrera-Almario, Monica Pinilla-Roncancio, David L. Tulloch, Sergio A Valencia
The Lancet. Global Health. 2020-05-01 - 6 citationsTargeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor ...Rachel NeMoyer, Arindam Mondal, Mehul Vora, Elaine Langenfeld, Danea Glover
Cell Communication and Signaling. 2019-11-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: